Skip to main content

Table 4 Reproductive, medical and clinical characteristics at randomisation

From: Breast cancer risk reduction - is it feasible to initiate a randomised controlled trial of a lifestyle intervention programme (ActWell) within a national breast screening programme?

 

Intervention (n = 40)

Control (n = 40)

All (n = 80)

Body weight (kg) mean (SD)

78.0 (16.5)

73.6 (18.7)

75.8 (17.7)

BMI (kg/m 2 ) mean (SD)

30.2 (6.5)

28.2 (7.4)

29.2 (7.0)

Smoking status

   

Current

4 (10.0%)

4 (10.0%)

8 (10.0%)

Never smoked

18 (45.0%)

25 (62.5%)

43 (53.8%)

Ex-smoker

18 (45.0%)

11 (27.5%)

29 (36.3%)

Cigarettes per day

   

Mean (SD) (consumers only)

11.3 (4.4)

9.5 (7.9)

10.4 (6.0)

Number of children

   

0

8 (20.0%)

8 (20.0%)

16 (20.0%)

1–2

21 (52.5%)

24 (60.0%)

45 (56.3%)

3-4

11 (27.5%)

8 (20.0%)

19 (23.8%)

Number of pregnancies

   

0

6 (15.0%)

7 (17.5%)

13 (16.3%)

1–2

16 (40.0%)

20 (40.0%)

36 (45.1%)

>3

18 (45.0%)

13 (32.5%)

31 (38.9%)

History of breastfeeding

18 (45.0%)

26 (65.0%)

44 (55.0%)

Family history of breast cancer

14 (35.0%)

21 (52.5%)

35 (43.8%)